|
|
|
Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment |
| Kaavya Jayaramayya, Iyer Mahalaxmi, Mohana Devi Subramaniam, Neethu Raj, Ahmed Abdal Dayem, Kyung Min Lim, Se Jong Kim, Jong Yub An, Yoonjoo Lee, Yujin Choi, Arthi Kirubhakaran, Ssang-Goo Cho & Balachandar Vellingiri |
BMB Reports 2020; 53(8): 400-412
 PDF  PubMed  PubMed Central  Google Scholar Search |
|
|
|
|
|
|
|
|
|
|
The activation of NLRP3 inflammasome potentiates the immunomodulatory abilities of mesenchymal stem cells in a murine colitis model |
| Ji-Su Ahn, Yoojin Seo, Su-Jeong Oh, Ji Won Yang, Ye Young Shin, Byung-Chul Lee, Kyung-Sun Kang, Eui-Suk Sung, Byung-Joo Lee, Hemn Mohammadpour, Jin Hur, Tae-Hoon Shin & Hyung-Sik Kim |
|
BMB Reports 2020; 53(6): 329-334
PDF PubMed PubMed Central Google Scholar Search |
|
|
|
|
|
|
|
